October 5th, 2007

For Your Consideration

Yesterday’s New York Times carried – for the second time in a week – a story highlighting the legal strategy the Johnson & Johnson affiliate company, Cordis Corp., took in a patent dispute with Boston Scientific. Last week, Cordis’s communications staff provided the newspaper with a statement explaining that case, but they chose not to include or reference the points raised in that statement in yesterday’s article. Have a look at their statement.


One Response to “For Your Consideration”

  1. Jim says

    The press release is interesting. It is what they should have said in the first place. However, first news reported is news remembered. I’m glad to see that the press stopped reporting further on the story, and hopefully people will forget the first story that came out.

Leave a Reply

All comments will be reviewed before posting. Since this blog is about Johnson & Johnson, comments that don’t directly relate to the Company or to topics covered on this blog won’t be posted. Please see our comments policy for details.